We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

8 hedge funds and large institutions have $208K invested in TriSalus Life Sciences Warrant in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

7.37% less ownership

Funds ownership: 8.07% → 0.71% (-7.4%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

58% less funds holding

Funds holding: 19 → 8 (-11)

85% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 13

94% less capital invested

Capital invested by funds: $3.71M → $208K (-$3.5M)

Holders
8
Holders Change
-11
Holders Change %
-57.89%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$19.8K
2
GS
GTS Securities
Florida
+$17.7K
3
FVWA
Foster Victor Wealth Advisors
South Carolina
+$1.34K

Top Sellers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
-$1.17M
2
DM
Deerfield Management
New York
-$543K
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$430K
4
MP
MSD Partners
New York
-$217K
5
BCM
Bluefin Capital Management
New York
-$211K

TLSIW Hedge Fund Activity: Q3 2024 in Review

8 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2024, worth a combined $208K — down 94% from $3.71M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of TLSIW and 2 opened new positions — a net loss of 11 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $19.8K. The largest seller was Magnetar Financial, exiting entirely with an estimated $1.17M sold.

  • 8 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2024, down from 19 in Q2 2024.
  • Funds reported $208K of TriSalus Life Sciences Warrant stock for Q3 2024, down 94% quarter-over-quarter.
  • 2 funds opened new TriSalus Life Sciences Warrant positions in Q3 2024 and 13 closed out, a net change of -11 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q3 2024 was Wolverine Asset Management, an estimated $19.8K added.
  • The largest TriSalus Life Sciences Warrant seller in Q3 2024 was Magnetar Financial, an estimated $1.17M sold.

Based on aggregated 13F filings for Q3 2024.